Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Preferred Stock Dividends, Income Statement Impact

1.7 / 5 stars · 18/54 Roast Me

Citius Pharmaceuticals, Inc. Preferred Stock Dividends, Income Statement Impact

Citius Pharmaceuticals, Inc. (CTXR) reported Preferred Stock Dividends, Income Statement Impact of $1.45 million for the 12-month period ending 2021-09-30, per its 10-K filed 2021-12-15.

Discontinued › Expense Statement › Operating Expenses

us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2021-12-15

  • Citius Pharmaceuticals, Inc. preferred stock dividends, income statement impact for the quarter ending 2021-09-30 was $0.00.
  • Citius Pharmaceuticals, Inc. preferred stock dividends, income statement impact for the quarter ending 2021-06-30 was $1.45M.
  • Citius Pharmaceuticals, Inc. preferred stock dividends, income statement impact for fiscal 2021 was $1.45M.
Period endPreferred Stock Dividends, Income Statement Impact 3 monthPreferred Stock Dividends, Income Statement Impact 6 monthPreferred Stock Dividends, Income Statement Impact 9 monthPreferred Stock Dividends, Income Statement Impact 12 month
2021-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15
$1.45M
derived: sum of 2 quarters · filed 2021-12-15
$1.45M
10-K · filed 2021-12-15
2021-06-30$1.45M
10-Q · filed 2021-08-12
$1.45M
10-Q · filed 2021-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36